Medifast, Inc.
MED
$13.40
$0.211.59%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.79% | -2.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.79% | -2.75% | |||
| Cost of Revenue | -8.17% | 2.27% | |||
| Gross Profit | -9.02% | -4.50% | |||
| SG&A Expenses | -9.34% | -1.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.86% | -1.10% | |||
| Operating Income | 15.53% | -278.00% | |||
| Income Before Tax | 446.58% | -58.75% | |||
| Income Tax Expenses | -69.57% | 173.84% | |||
| Earnings from Continuing Operations | 421.24% | -196.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 421.24% | -196.38% | |||
| EBIT | 15.53% | -278.00% | |||
| EBITDA | 47.62% | -84.58% | |||
| EPS Basic | 420.00% | -196.31% | |||
| Normalized Basic EPS | 445.00% | -58.85% | |||
| EPS Diluted | 412.06% | -200.86% | |||
| Normalized Diluted EPS | 441.67% | -58.68% | |||
| Average Basic Shares Outstanding | 0.39% | 0.09% | |||
| Average Diluted Shares Outstanding | 1.02% | -0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.00% | -- | |||